49 results
10-K
2023 FY
EX-10.22
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
to the Company in accordance with the Company’s applicable expense reimbursement policies and procedures as are in effect from time to time.
(e)Vacation … of separate and distinct payments; and (iii) to the extent that any reimbursement of expenses or in-kind benefits constitutes “deferred compensation” under
10-K
2023 FY
EX-10.23
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
in the performance of Executive’s duties to the Company in accordance with the Company’s applicable expense reimbursement policies and procedures as are in effect … payments shall be treated as a right to receive a series of separate and distinct payments; and (iii) to the extent that any reimbursement of expenses
10-K
2023 FY
EX-97.1
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation or Erroneously Awarded Compensation, reimbursement
10-K
c7z wuaz16r3
7 Mar 24
Annual report
4:05pm
10-Q
ssrcp6w6ajb2inmvv0b
1 Nov 23
Quarterly report
4:05pm
S-8
1un lym9xrt5pulccaz
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
1py3qa
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
ul4gyw7e
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
gjnq7x jrp5
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-10.21
10ehn
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-10.13
71ciwbc
11 Sep 23
IPO registration (amended)
6:07am
S-1
4xklo3
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
k7j5gn8x8e3
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.12
kmg3jduh5x49ixb
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
ft8uc 4bzs
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
sk00 84ophuwy
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.4
j9d gdcbj
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.11
g4hdmn
25 Aug 23
IPO registration
5:03pm